{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:26:32Z","timestamp":1788449192017,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02362950"],"award-info":[{"award-number":["RF-2016-02362950"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ERARE14-fp-097 - CHAPRION"],"award-info":[{"award-number":["ERARE14-fp-097 - CHAPRION"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP10208"],"award-info":[{"award-number":["GGP10208"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nbd.2021.105455","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:09:10Z","timestamp":1628046550000},"page":"105455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Doxycycline rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice"],"prefix":"10.1016","volume":"158","author":[{"given":"Giada","family":"Lavigna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Masone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihssane","family":"Bouybayoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Imeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Restelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105455_bb0005","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0600554103","article-title":"Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations","volume":"103","author":"Alano","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105455_bb0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2019.00738","article-title":"Doxycycline for Alzheimer\u2019s disease: fighting \u03b2-amyloid oligomers and neuroinflammation","volume":"10","author":"Balducci","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105455_bb0015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105455_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2021.105455_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004796","article-title":"Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease","volume":"11","author":"Bouybayoune","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2021.105455_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/9780470942390.mo110217","article-title":"Health evaluation of experimental laboratory mice","volume":"2","author":"Burkholder","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/nbdi.2001.0433","article-title":"Prion diseases: what is the neurotoxic molecule?","volume":"8","author":"Chiesa","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105455_bb0040","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0896-6273(00)80653-4","article-title":"Neurological illness in transgenic mice expressing a prion protein with an insertional mutation","volume":"21","author":"Chiesa","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105455_bb0045","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1073\/pnas.97.10.5574","article-title":"Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation","volume":"97","author":"Chiesa","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105455_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/19336896.2016.1139276","article-title":"Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: role of intracellular PrP retention in neurotoxicity","volume":"10","author":"Chiesa","year":"2016","journal-title":"Prion"},{"key":"10.1016\/j.nbd.2021.105455_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105455_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-62703-791-4_9","article-title":"Behavioral methods for the study of the Ras-ERK pathway in memory formation and consolidation: passive avoidance and novel object recognition tests","volume":"1120","author":"d\u2019Isa","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuron.2008.09.008","article-title":"Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model","volume":"60","author":"Dossena","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105455_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2021.105455_bb0075","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105455_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","article-title":"Preventive study in subjects at risk of fatal familial insomnia: innovative approach to rare diseases","volume":"9","author":"Forloni","year":"2015","journal-title":"Prion"},{"key":"10.1016\/j.nbd.2021.105455_bb0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1439789","article-title":"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism","volume":"258","author":"Goldfarb","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.nbd.2021.105455_bb0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fnins.2020.00896","article-title":"A non-invasive digital biomarker for the detection of rest disturbances in the SOD1G93A mouse model of ALS","volume":"14","author":"Golini","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2021.105455_bb0095","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1093\/hmg\/ddy152","article-title":"PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sj\u00f6gren syndrome","volume":"27","author":"Grande","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105455_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","article-title":"Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents","volume":"285","author":"Grayson","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2021.105455_bb0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2021.105455_bb0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/acn3.498","article-title":"An in vivo 11C-PK PET study of microglia activation in fatal familial insomnia","volume":"5","author":"Iaccarino","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2021.105455_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01454","article-title":"Non-intrusive high throughput automated data collection from the home cage","volume":"5","author":"Iannello","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.nbd.2021.105455_bb0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1742-2094-8-152","article-title":"Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid \u03b2","volume":"8","author":"Kauppinen","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2021.105455_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0140","first-page":"57","article-title":"Rfit: Rank-based estimation for linear models","volume":"4","author":"Kloke","year":"2012","journal-title":"R Journal."},{"key":"10.1016\/j.nbd.2021.105455_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awy318","article-title":"Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects","volume":"142","author":"La Vitola","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105455_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.118.252064","article-title":"Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice","volume":"368","author":"Lucchetti","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2021.105455_bb0155","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.12681.1","article-title":"Creutzfeldt-Jakob disease: recent developments","volume":"6","author":"Mackenzie","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.nbd.2021.105455_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1242\/dev.115.1.117","article-title":"The prion protein gene: a role in mouse embryogenesis?","volume":"115","author":"Manson","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.nbd.2021.105455_bb0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.exger.2005.07.005","article-title":"Protein degradation and aging","volume":"40","author":"Martinez-Vicente","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2021.105455_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0012-1606(87)90143-6","article-title":"Developmental expression of prion protein gene in brain","volume":"121","author":"McKinley","year":"1987","journal-title":"Dev. Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2021.105455_bb0180","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105455_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1750-3639.1998.tb00172.x","article-title":"Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene","volume":"8","author":"Montagna","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2021.105455_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","article-title":"Familial and sporadic fatal insomnia","volume":"2","author":"Montagna","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2021.105455_bb0195","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","article-title":"Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington\u2019s disease","volume":"57","author":"Paldino","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105455_bb0200","series-title":"In|Fo|Neurologie & Psychiatrie","first-page":"2","article-title":"Prionerkrankungen\u2014welche Rolle spielen sie heute?","author":"Ponto","year":"2013"},{"key":"10.1016\/j.nbd.2021.105455_bb0205","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105455_bb0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","article-title":"The neuroprotective effect of doxycycline on neurodegenerative diseases","volume":"35","author":"Santa-Cec\u00edlia","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2021.105455_bb0215","first-page":"65","article-title":"Self management of fatal familial insomnia. Part 1: what is FFI?","volume":"8","author":"Schenkein","year":"2006","journal-title":"Medscape Gen. Med."},{"key":"10.1016\/j.nbd.2021.105455_bb0220","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/jm400161p","article-title":"A new face for old antibiotics: tetracyclines in treatment of amyloidoses","volume":"56","author":"Stoilova","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2021.105455_bb0225","series-title":"Alzheimers Dement","first-page":"T149","article-title":"Prion therapy: tetracyclic compounds in animal models and patients with Creutzfeldt-Jakob disease","author":"Tagliavini","year":"2008"},{"key":"10.1016\/j.nbd.2021.105455_bb0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2021.105455_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: a double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105455_bb0240","doi-asserted-by":"crossref","first-page":"575434","DOI":"10.3389\/fnbeh.2020.575434","article-title":"Three pillars of automated home-cage phenotyping of mice: novel findings, refinement, and reproducibility based on literature and experience","volume":"14","author":"Voikar","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105455_bb0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coph.2019.02.002","article-title":"Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds","volume":"44","author":"Vorberg","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105455_bb0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-016-1585-6","article-title":"Towards authentic transgenic mouse models of heritable PrP prion diseases","volume":"132","author":"Watts","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2021.105455_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/sleep\/34.3.261","article-title":"Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss","volume":"34","author":"Wisor","year":"2011","journal-title":"Sleep"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:28:15Z","timestamp":1760851695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S0969996121002047"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105455","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105455"}}